Risk factors
Corcept Therapeutics (CORT) risk factors
Item 1A of every Corcept Therapeutics Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors28 risks3 new2 dropped10 reworded
FDA and other agency disruptions, Medicaid cuts, and tariff changes now threaten approvals, costs, reimbursement, and patient-assistance spending.
Filed Feb 24, 2026 - FY2024 10-K risk factors30 risks
Teva launched a generic Korlym in January 2024 after a court found it would not infringe Corcept’s asserted patents.
Filed Feb 26, 2025